VIE/ZOTS (VIE/ZOTS)

Vienna Stock Exchange: VIE/ZOTS · EUR

€69.4

-1.24 (-1.8%)· Recorded snapshot

Market cap	28.8B
Revenue (ttm)	8.3B
Net income (ttm)	2.3B
EPS (ttm)	€5.49
P/E (trailing)	12.6x
P/E (forward)	12.9x
Dividend	€1.84 (2.65%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 8.3B
Net income (ttm): 2.3B
EPS (ttm): €5.49
P/E (trailing): 12.6x
P/E (forward): 12.9x
Market cap: 28.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E12.9

P25 n/aP50 n/aP75 n/a

Trailing P/E12.6

P25 n/aP50 n/aP75 n/a

ROE64.9

P25 n/aP50 n/aP75 n/a

ROIC27.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/ZOTS indicators

Market & fundamental data

Available fields

243

Groups with data

Currency

USD

Showing 243 of 243 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	AT
Earnings date	2026-11-05
Employees	14,500
Employees change	700
Employees growth	5.07%
Enterprise value	EUR 35.6B
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2012
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	US98978V1035
Last earnings date	2026-08-06
Last refreshed	2026-10-29
Market cap	EUR 28.8B
Next earnings date	2026-11-05
Price	EUR 69.40
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	vie/ZOTS
Website	https://www.zoetis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	35.79x
Average P/E ratio (3Y)	28.15x
Average P/E ratio (5Y)	33.08x
Earnings yield	7.91%
EV/Earnings	15.44x
EV/EBIT	10.94x
EV/EBITDA	9.49x
EV/FCF	17.58x
EV/Sales	4.17x
FCF / EV yield	5.69%
FCF yield	7.03%
Forward P/E	12.87x
Graham number	28.78234
Graham upside	-58.53%
Lynch fair value	EUR 37.07
Lynch upside	-46.59%
P/(FCF - SBC) ratio	14.84x
P/(OCF - SBC) ratio	12x
P/B ratio	10.47x
P/E ratio	12.64x
P/FCF ratio	14.23x
P/OCF ratio	11.6x
P/S ratio	3.46x
Price/EBITDA ratio	8.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	38.11%
EBITDA margin	42.69%
Effective tax rate	20.07%
FCF margin	23.76%
Gross margin	71.74%
Operating margin	38.11%
Pretax margin	34.64%
Profit margin	27.69%
Profit per employee	EUR 159,184
Profitable quarters	44
Profitable years	16
Revenue per employee	EUR 574,982
ROA	15.35%
ROA (5Y)	13.76%
ROCE	27.89%
ROE	64.91%
ROE (5Y)	52.61%
ROIC	27.28%
ROIC (5Y)	28.07%
SBC / revenue	1%
Tax / revenue	6.95%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	6.23%
EPS growth (Q)	1.23%
EPS growth (QoQ)	16.2%
EPS growth 10Y	16.92%
EPS growth 3Y	8.9%
EPS growth 5Y	8.97%
EPS growth quarters	8
EPS growth years	10
FCF growth	2.07%
FCF growth (Q)	17.21%
FCF growth (QoQ)	84.88%
FCF growth 3Y	21.7%
FCF growth 5Y	6.35%
Gross profit growth	2.12%
Gross profit growth (Q)	-0.77%
Gross profit growth 3Y	5.77%
Gross profit growth 5Y	5.76%
Net income growth	1.78%
Net income growth (Q)	-4.82%
Net income growth (QoQ)	14.98%
Net income growth 3Y	6.02%
Net income growth 5Y	6.67%
Net income growth years	10
OCF growth	-4.57%
OCF growth (Q)	8.26%
OCF growth (QoQ)	63.34%
OCF growth 10Y	15.54%
OCF growth 3Y	12.42%
OCF growth 5Y	5.62%
Operating income growth	3.15%
Operating income growth (Q)	-0.3%
Operating income growth 3Y	6.76%
Operating income growth 5Y	6.26%
Revenue growth	1.58%
Revenue growth (Q)	-0.24%
Revenue growth (QoQ)	9.11%
Revenue growth 10Y	6.96%
Revenue growth 3Y	5.03%
Revenue growth 5Y	5.14%
Revenue growth years	10

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -458.7M
Depreciation and amortization	EUR 390.6M
EBIT	EUR 3.2B
EBITDA	EUR 3.6B
EPS	EUR 5.49
Financing cash flow	EUR -2B
Free cash flow	EUR 2B
Free cash flow minus SBC	EUR 1.9B
Gross profit	EUR 6B
Income taxes	EUR 579.4M
Investing cash flow	EUR -630.2M
Net borrowing	EUR 2.1B
Net cash flow	EUR -146.2M
Net income	EUR 2.3B
Operating cash flow minus SBC	EUR 2.4B
Operating income	EUR 3.2B
Revenue	EUR 8.3B
Stock-based compensation	EUR 83.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.87
Book value per share	EUR 6.65
Debt / EBITDA	2.21
Debt / equity	2.94
Debt / FCF	4
Goodwill	EUR 2.5B
Interest coverage	15.25
Long-term assets	EUR 7.5B
Long-term liabilities	EUR 8.6B
Net cash (debt)	EUR -6.6B
Net cash / market cap	-23%
Net debt / EBITDA	1.86
Net debt / equity	2.41
Net debt / FCF	3.27
Piotroski F-Score	6
Property, plant and equipment	EUR 3.6B
Shareholders' equity	EUR 2.8B
Tangible book value	EUR -473.5M
Tangible book value per share	EUR -1.14
Total assets	EUR 13.2B
Total cash	EUR 1.5B
Total debt	EUR 8.1B
Total liabilities	EUR 10.4B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.64
Current assets	EUR 5.7B
Current liabilities	EUR 1.8B
Current ratio	3.08
Inventory turnover	1.07
Net working capital	EUR 2.3B
Quick ratio	1.58
Working capital	EUR 3.8B
Working capital turnover	2.43

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	4.22%
Dividend growth	3.2%
Dividend growth (3Y)	10.15%
Dividend growth (5Y)	16.92%
Dividend growth years	6
Dividend payment date	2026-12-01
Dividend payment years	8
Dividend payout frequency	Quarterly
Dividend per share	EUR 1.84
Dividend yield	2.65%
Ex-dividend date	2026-10-30
Last dividend	EUR 0.47
Payout ratio	33.71%
Shareholder yield	6.87%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 72.44
1D price change	-1.76%
1M price change	13.36%
1M total return	13.36%
1W price change	-2.31%
1W total return	-2.31%
1Y price change	-45.31%
1Y return CAGR	-44.28%
1Y total return	-44.26%
20-day SMA	EUR 67.42
200-day SMA	EUR 80.81
3M price change	1.94%
3M total return	1.94%
3Y price change	-53.3%
3Y return CAGR	-21.35%
3Y total return	-51.35%
50-day SMA	EUR 65.51
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 126.46
52-week high date	2025-10-28
52-week low	EUR 61.22
52-week low date	2026-09-25
5Y price change	-61.75%
5Y return CAGR	-16.56%
5Y total return	-59.55%
6M price change	-31.52%
6M total return	-31.05%
All-time high	EUR 220.30
All-time high date	2021-12-30
All-time low	EUR 61.22
All-time low date	2026-09-25
Average true range (ATR)	EUR 1.18
Average volume	0
Change from 52-week high	-45.12%
Change from 52-week low	13.36%
Change from all-time high	-68.5%
Change from all-time low	13.36%
Change from open	-0.69%
Day's gap	-1.08%
High price	EUR 69.88
Low price	EUR 69.40
Monthly RSI	30.42
Open price	EUR 69.88
Position in 52-week range	0%
Previous close	EUR 70.64
Price vs 150-day SMA	-4.2%
Price vs 20-day SMA	2.94%
Price vs 200-day SMA	-14.12%
Price vs 50-day SMA	5.93%
Relative volume	18.02
RSI	57.64
Sharpe ratio	-1.36
Sharpe ratio (3Y)	-0.85
Sharpe ratio (5Y)	-0.57
Sortino ratio	-1.46
Sortino ratio (3Y)	-0.89
Sortino ratio (5Y)	-0.54
Weekly RSI	44.15
YTD price change	-35.56%
YTD total return	-34.55%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	412.4M
Shares change (QoQ)	-1.11%
Shares change (YoY)	-4.22%
Shares held by insiders	0.1%
Shares held by institutions	98.41%
Short ratio	3.5 days

Deeper analysis on VIE/ZOTS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/ZOTS report

Is a complete VIE/ZOTS research report available?

No complete published report is available for vie/ZOTS (VIE/ZOTS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/ZOTS (VIE/ZOTS)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/ZOTS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/ZOTS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/ZOTS

Frequently asked questions